Drug Channels

Expert insights by Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system (RSS feed)

 

The AI Advantage: Evolving Patient Engagement Strategies to Improve Outcomes
2025-08-01 11:54 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.)

Today’s guest post comes from Stacey Little, Chief Growth Officer at AssistRx.

In this guest post, Stacey explores how artificial intelligence (AI) is helping life sciences organizations move beyond fragmented support models to deliver more integrated and personalized patient engagement. She outlines three distinct approaches to structuring patient support programs and discusses how AI-driven tools—such as AllazoHealth—can help tailor interventions across the entire treatment journey.

To learn more, see the AssistRx case study: Sophisticated Patient Engagement Programs that Improve Experiences and Outcomes.

Read on for Stacey’s insights.
Read more »
       

 

Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative.